Abstract

Aims We examined the clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary angioplasty or thrombolytic therapy for acute myocardial infarction.

Methods and Results We studied 2635 patients enrolled in 10 randomized trials of primary angioplasty (n=1302) vs thrombolytic therapy (n=1333) in acute myocardial infarction, and baseline characteristics of the two groups were comparable. Increase in presentation delay is associated with older age, female gender, diabetes and an increased heart rate. We classified the patients according to the time delay from symptom onset to presentation into three categories: early presentation (<2h), intermediate presentation (2–4h), and late presentation (≥4h). At 30 days the combined rate of death, non-fatal reinfarction and stroke in patients presenting early was 5·8% in the angioplasty group vs 12·5% in the thrombolysis group, in patients with intermediate presentation, 8·6% vs 14·2%, respectively, and in patients presenting late 7·7% vs 19·4%, respectively. With increasing time from symptom onset to presentation, all major adverse cardiac event rates show a trend to a larger increase in the thrombolysis group compared to the angioplasty group, both at 30 days and at 6 months after the acute event.

Conclusions Major adverse cardiac event rates are lower after angioplasty compared to thrombolysis, irrespective of time to presentation. With increasing time to presentation major adverse cardiac event rates increase after thrombolysis but appear to remain relatively stable after angioplasty.

f1
Correspondence: Dr Felix Zijlstra, Hospital de Weezenlanden, Department of Cardiology, Groot Wezenland 20, 8011 JW Zwolle, The Netherlands.

References

1
Lancet
 .
1994
;
343
:
311
–322
2
Weaver
WD
, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative overview.
JAMA
 .
1997
;
278
:
2093
–2098
3
Boersma
E
, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.
Lancet
 .
1996
;
348
:
771
–775
4
O'Neill
WW
, de Boer MJ, Gibbons RJ. Lessons from the pooled outcome of the PAMI, Zwolle and Mayo Clinic randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction.
J Invas Cardiol
 .
1998
;
10
:
4A
–10A
5
Steg
PG
, Laperche T, Golmard JL. Efficacy of streptokinase, but not issue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment.
J Am Coll Cardiol
 .
1998
;
31
:
776
–779
6
Zeymer
U
, Tebbe U, von Essen R, Haarmann W, Neuhaus KL. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens.
Am Heart J
 .
1999
;
137
:
34
–38
7
Brodie
BR
, Stuckey TD, Wall TC. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.
J Am Coll Cardiol
 .
1998
;
32
:
1312
–1319
8
van't Hof
AWJ
, Liem AL, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.
Eur Heart J
 .
1998
;
19
:
118
–123
9
Cannon
CP
, Gibson CM, Lambrew CT. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.
JAMA
 .
2000
;
283
:
2941
–2947
10
Berger
PB
, Ellis SG, Holmes DR Jr. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial.
Circulation
 .
1999
;
100
:
14
–20
11
Weaver
WD
. Time to thrombolytic treatment: factors affecting delay and their influence on outcome.
J Am Coll Cardiol
 .
1995
;
25
:
3S
–9S
12
Lee
KL
, Woodlief LH, Topol EJ. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients.
Circulation
 .
1995
;:
1659
–1668
13
Zijlstra
F
, de Boer MJ, Hoorntje JCA. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction.
N Engl J Med
 .
1993
;
328
:
680
–684
14
Ribeiro
EE
, Silva LA, Carneiro R. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.
J Am Coll Cardiol
 .
1993
;
22
:
376
–380
15
Grinfeld
L
, Berrocal D, Belardi J. Fibrinolytics versus primary angioplasty in acute myocardial infarction (FAP) (Abstr).
J Am Coll Cardiol
 .
1996
;
27
:
A-222
16
Zijlstra
F
, Beukema WP, van't Hof AWJ. Randomized comparison of primary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction.
J Am Coll Cardiol
 .
1997
;
29
:
908
–912
17
Garcia
E
, Elizaga J, Perez-Castellano N. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction.
J Am Coll Cardiol
 .
1999
;
33
:
605
–611
18
Grines
CL
, Browne KF, Marco JL. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction.
N Engl J Med
 .
1993
;
328
:
673
–679
19
Gibbons
RJ
, Holmes DR, Reeder GS, Bayley KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction.
N Engl J Med
 .
1993
;
328
:
685
–691
20
N Engl J Med
 .
1997
;
336
:
1621
–1628
21
Akhras
F
, Ousa AA, Swann G. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a new cardiac unit (Abstr).
J Am Coll Cardiol
 .
1997
;
29
:
A-235
–A-236
22
Ribichini
F
, Steffenino G, Dellavalle A. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression. Immediate and long-term results of a randomized study.
J Am Coll Cardiol
 .
1998
;
32
:
1687
–1694
23
DeWood
MA
. Direct PTCA versus intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. Proceedings from the Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI. Washington: George Washington University; 1990. p. 28–29
24
Wald
A
. Tests of statistical hypotheses concerning several parameters when the number of observations is large.
Trans Am Math Soc
 .
1943
;
54
:
426
–482
25
Flameng
W
, Lesaffre E, Vanhaecke J. Determinants of infarct size in non-human primates.
Bas Res Cardiol
 .
1990
;
85
:
392
–403
26
Reimer
KA
, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.
Am J Cardiol
 .
1993
;
72
:
13G
–21G
27
Dorado
DG
, Théroux P, Elizaga J. Myocardial infarction in the pig heart model: infarct size and duration of coronary occlusion.
Cardiovasc Res
 .
1987
;
21
:
537
–544
28
Liem
AL
, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Suryapranata H, Zijlstra F. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty.
J Am Coll Cardiol
 .
1998
;
32
:
629
–633
29
Milavetz
JJ
, Giebel DW, Christian TF, Schwartz RS, Holmes DR, Gibbons RJ. Time to therapy and salvage in myocardial infarction.
J Am Coll Cardiol
 .
1998
;
31
:
1246
–1251
30
Chareonthaitawee
P
, Gibbons RJ, Roberts RS, Christian TF, Burns R, Yusuf S. The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction.
Heart
 .
2000
;
84
:
142
–148
31
N Engl J Med
 .
1993
;
329
:
673
–682
32
Newby
LK
, Rutsch WR, Califf RM. Time from symptom onset to treatment and outcomes after thrombolytic therapy.
J Am Coll Cardiol
 .
1996
;
27
:
1646
–1655
33
Eur Heart J
 .
1996
;
17
:
43
–63
34
Zijlstra
F
. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction.
Eur Heart J
 .
2000
;
21
:
1487
–1489
35
Kimmel
SE
, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications.
JAMA
 .
1996
;
274
:
1137
–1142
36
Christian
TF
, O'Keefe JH, DeWood MA. Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction.
Am Heart J
 .
1998
;
135
:
310
–317
37
Caputo
RP
, Ho KKL, Stoler RC. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
Am J Cardiol
 .
1997
;
79
:
1159
–1164
38
Zijlstra
F
, Hoorntje JCA, de Boer MJ. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
N Engl J Med
 .
1999
;
341
:
1413
–1419

Comments

0 Comments